Pdf

Small Cap News: Synchronica, Stanley Gibbons, Fusion IP, Planet Payment, Advanced Computer Software

4th Sep 2010, 5:01 pm Small Cap News: Synchronica, Stanley Gibbons, Fusion IP, Planet Payment, Advanced Computer Software

Small caps performed strongly this week with the FTSE AIM 100 and FTSE AIM All-Share indexes surging 3.3%.

Synchronica (LON:SYNC) believes that the proposed iseemedia (TSX-V:IEE) acquisition will position the company as a market leader for next-generation mobile messaging.

Retailer of stamps and other collectibles Stanley Gibbons (LON:SGI) has bought the business and certain assets of specialist stamp dealer Nigel Haworth, formerly M & N Haworth, for £0.3 million.

University IP commercialisation company Fusion IP (LON:FIP) has said that its Sheffield-based biotechnology company Absynth Biologics has signed a licensing and collaboration agreement with MorphoSys AG.

Researchers will now have free online access to AIM listed Cyprotex PLC's (LON:CRX) database of the ADME and pharmacokinetic properties of marketed drugs, the company announced today. Cyprotex provides data about potential new drugs and specialises in the preclinical ADME assessment of drug candidates.

Daniel Stewart & Company (DS&C) said that Mastercard’s acquisition of Datacash has made payment and card services business Planet Payment (LON:PPT) look cheap relative to its peers.

Advanced Computer Software (LON:ASW) announced today it has signed a five-year contract worth up to £5.2 million with the Nursing and Midwifery Council (NMC). The company will manage and host the organisation’s IT infrastructure across two different data centres.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.